Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Vevorisertib

🥰Excellent
Catalog No. T38847Cas No. 1416775-46-6
Alias ARQ751, ARQ 751

Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor with inhibitory effects on AKT1/AKT2/AKT3 and is commonly used in the study of solid tumors with PIK3CA/AKT/PTEN mutations, showing dose-dependent antitumor activity.

Vevorisertib

Vevorisertib

🥰Excellent
Purity: 99.14%
Catalog No. T38847Alias ARQ751, ARQ 751Cas No. 1416775-46-6
Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor with inhibitory effects on AKT1/AKT2/AKT3 and is commonly used in the study of solid tumors with PIK3CA/AKT/PTEN mutations, showing dose-dependent antitumor activity.
Pack SizePriceAvailabilityQuantity
1 mg$162 In Stock
5 mg$396 In Stock
10 mg$752 In Stock
25 mg$1,650 In Stock
50 mg$2,620 In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.14%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor with inhibitory effects on AKT1/AKT2/AKT3 and is commonly used in the study of solid tumors with PIK3CA/AKT/PTEN mutations, showing dose-dependent antitumor activity.
Targets&IC50
Akt2:0.81 nM, Akt3:1.31 nM, Akt3:1.31 nM (IC50), Akt1:0.55 nM, Akt2:0.81 nM (IC50), Akt1:0.55 nM (IC50)
In vitro
Vevorisertib binds to wild-type AKT1 and mutant AKT1-E17K with Kd of 1.2 nM and 8.6 nM, respectively, and inhibits pAKT(S473) in 293T cells transiently transfected with AKT1-E17K.[4]
In vivo
Vevorisertib (10-120 mg/kg) has dose-dependent antitumor activity in AKT1-E17K mutant endometrial patient xenograft (PDX) models.[4]
AliasARQ751, ARQ 751
Chemical Properties
Molecular Weight586.73
FormulaC35H38N8O
Cas No.1416775-46-6
SmilesO=C(N(C)C1CCN(C2=CC=CC(=C2)C3=NC4=C(N=C(C5=CC=CN=C5N)N4C6=CC=C(C=C6)C7(N)CCC7)C=C3)CC1)C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 4.00 mg/mL (6.82 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7044 mL8.5218 mL17.0436 mL85.2181 mL
5 mM0.3409 mL1.7044 mL3.4087 mL17.0436 mL

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vevorisertib | purchase Vevorisertib | Vevorisertib cost | order Vevorisertib | Vevorisertib chemical structure | Vevorisertib in vivo | Vevorisertib in vitro | Vevorisertib formula | Vevorisertib molecular weight